Asembia’s 2021 Specialty Pharmacy Summit

Asembia 2021: George Van Antwerp of Deloitte Dissects the Relationship Between Health Equity and Specialty Pharmacy

October 28, 2021

George Van Antwerp, pharmacy and PBM leader of Deloitte, presents at the Asembia 2021 Specialty Pharmacy Summit and shares framework of specialty pharmacy.

Asembia 2021: Steve Peskin of Horizon BCBS of NJ Talks Value-Based Contracting Between Payers & Pharma Companies

October 27, 2021

Steve Peskin of Horizon BCBS of NJ, executive medical director of Population Health at Horizon Blue Cross Blue Shield of New Jersey, shares forms of value-based contracting between payers and pharmaceutical companies.

Asembia 2021: Lance Grady of Avalere Health Shares His Outlook of Specialty Pharmacy After COVID-19 Public Health Emergency

October 27, 2021

Lance Grady, head of Market Access at Avalere Health, gives a preview of his presentation he gives at Asembia and discusses the significant changes made to specialty pharmacy because of the COVID-19 public health emergency.

Asembia 2021: Specialty is a Growing Share of the Pharma Market. PBMs, Health Systems Are Vying for That Larger Slice of the Pie.

October 27, 2021

Pharma industry experts Adam Fein, Ph.D., and Doug Long, MBA, described the growth of specialty pharmacy and the competition for that part of the pharma market during the opening presentation today at the Asembia 2021 Specialty Pharmacy Summit in Las Vegas.